167 related articles for article (PubMed ID: 36788099)
1. Frequent Intraluminal Growth of Large Muscular Veins in Surgically Resected Colorectal Cancer Tissues: A 3-Dimensional Pathologic Reconstruction Study.
Jung D; Shin J; Park J; Shin J; Sung YN; Kim Y; Yoo S; Lee BW; Jang SW; Park IJ; Wood LD; Pack CG; Hruban RH; Hong SM
Mod Pathol; 2023 Mar; 36(3):100082. PubMed ID: 36788099
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional visualization of cleared human pancreas cancer reveals that sustained epithelial-to-mesenchymal transition is not required for venous invasion.
Hong SM; Jung D; Kiemen A; Gaida MM; Yoshizawa T; Braxton AM; Noë M; Lionheart G; Oshima K; Thompson ED; Burkhart R; Wu PH; Wirtz D; Hruban RH; Wood LD
Mod Pathol; 2020 Apr; 33(4):639-647. PubMed ID: 31700162
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional analysis of extrahepatic cholangiocarcinoma and tumor budding.
Yoshizawa T; Hong SM; Jung D; Noë M; Kiemen A; Wu PH; Wirtz D; Hruban RH; Wood LD; Oshima K
J Pathol; 2020 Aug; 251(4):400-410. PubMed ID: 32476131
[TBL] [Abstract][Full Text] [Related]
5. Desmin and CD31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers.
Shin J; Wood LD; Hruban RH; Hong SM
PLoS One; 2020; 15(11):e0242571. PubMed ID: 33253282
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-mesenchymal transition during oncogenic transformation induced by hexavalent chromium involves reactive oxygen species-dependent mechanism in lung epithelial cells.
Ding SZ; Yang YX; Li XL; Michelli-Rivera A; Han SY; Wang L; Pratheeshkumar P; Wang X; Lu J; Yin YQ; Budhraja A; Hitron AJ
Toxicol Appl Pharmacol; 2013 May; 269(1):61-71. PubMed ID: 23518002
[TBL] [Abstract][Full Text] [Related]
7. Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice.
Bi X; Pohl NM; Qian Z; Yang GR; Gou Y; Guzman G; Kajdacsy-Balla A; Iozzo RV; Yang W
Carcinogenesis; 2012 Feb; 33(2):326-30. PubMed ID: 22159220
[TBL] [Abstract][Full Text] [Related]
8. Thymosin β 4 in colorectal cancer is localized predominantly at the invasion front in tumor cells undergoing epithelial mesenchymal transition.
Nemolato S; Restivo A; Cabras T; Coni P; Zorcolo L; Orrù G; Fanari M; Cau F; Gerosa C; Fanni D; Messana I; Castagnola M; Casula G; Faa G
Cancer Biol Ther; 2012 Feb; 13(4):191-7. PubMed ID: 22233609
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
10. Rab11 regulates E-cadherin expression and induces cell transformation in colorectal carcinoma.
Chung YC; Wei WC; Huang SH; Shih CM; Hsu CP; Chang KJ; Chao WT
BMC Cancer; 2014 Aug; 14():587. PubMed ID: 25117932
[TBL] [Abstract][Full Text] [Related]
11. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin.
Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F
J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma: Characterization in a 3D-cell culture model.
Gagliano N; Celesti G; Tacchini L; Pluchino S; Sforza C; Rasile M; Valerio V; Laghi L; Conte V; Procacci P
World J Gastroenterol; 2016 May; 22(18):4466-83. PubMed ID: 27182158
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
[TBL] [Abstract][Full Text] [Related]
14. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps.
Na TY; Schecterson L; Mendonsa AM; Gumbiner BM
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5931-5937. PubMed ID: 32127478
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 expression is related to the epithelial-to-mesenchymal transition in human colon cancers.
Jang TJ; Jeon KH; Jung KH
Yonsei Med J; 2009 Dec; 50(6):818-24. PubMed ID: 20046424
[TBL] [Abstract][Full Text] [Related]
16. Metastatic seeding of human colon cancer cell clusters expressing the hybrid epithelial/mesenchymal state.
Mizukoshi K; Okazawa Y; Haeno H; Koyama Y; Sulidan K; Komiyama H; Saeki H; Ohtsuji N; Ito Y; Kojima Y; Goto M; Habu S; Hino O; Sakamoto K; Orimo A
Int J Cancer; 2020 May; 146(9):2547-2562. PubMed ID: 31506938
[TBL] [Abstract][Full Text] [Related]
17. Loss of N-Cadherin Expression in Tumor Transplants Produced From As+3- and Cd+2-Transformed Human Urothelial (UROtsa) Cell Lines.
Sandquist EJ; Somji S; Dunlevy JR; Garrett SH; Zhou XD; Slusser-Nore A; Sens DA
PLoS One; 2016; 11(5):e0156310. PubMed ID: 27224422
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin knockdown increases β-catenin reducing colorectal cancer chemosensitivity only in three-dimensional cultures.
Liang X; Xu X; Wang F; Chen X; Li N; Wang C; He J
Int J Oncol; 2015 Oct; 47(4):1517-27. PubMed ID: 26316041
[TBL] [Abstract][Full Text] [Related]
19. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.
Xiong H; Hong J; Du W; Lin YW; Ren LL; Wang YC; Su WY; Wang JL; Cui Y; Wang ZH; Fang JY
J Biol Chem; 2012 Feb; 287(8):5819-32. PubMed ID: 22205702
[TBL] [Abstract][Full Text] [Related]
20. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
